Key result
FDG-PET is evaluated for its diagnostic utility in the clinical work-up of pulmonary artery sarcomas.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
FDG-PET may refine pulmonary artery sarcoma diagnostics; leaves open routine adoption without prospective validation.
Tueller et al. (2010) studied this question. FDG-PET is evaluated for its diagnostic utility in the clinical work-up of pulmonary artery sarcomas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: